Value of weight reduction in patients with cardiovascular disease

被引：19

作者：

Artham S.M. ^{[1
]}

Lavie C.J. ^{[1
]}

Milani R.V. ^{[1
]}

Ventura H.O. ^{[1
]}

机构：

[1] Ochsner Medical Center, New Orleans, LA 70121

来源：

Current Treatment Options in Cardiovascular Medicine | 2010年 / 12卷 / 1期

关键词：

Obstructive Sleep Apnea; Bariatric Surgery; Gastric Banding; Naltrexone; Orlistat;

D O I：

10.1007/s11936-009-0056-y

中图分类号：

学科分类号：

摘要：

Opinion statement: Obesity is an independent risk factor for cardiovascular (CV) disease and contributes markedly to individual CV risk factors, including hypertension, diabetes mellitus, dyslipidemia, and other chronic conditions, such as osteoarthritis, obstructive sleep apnea, and physical deconditioning. Obesity, defined as a body mass index ≥30 kg/m2, is associated with increased morbidity and mortality, particularly in severely obese patients with a body mass index ≥35 kg/m2. Physical activity, healthy eating and behavioral modification are three pivotal approaches to treating obesity. Some individuals may benefit from pharmacologic agents to achieve meaningful weight loss. Unfortunately, there are few such agents at present with proven efficacy and safety profiles. In this review, we discuss the obesity epidemic and its detrimental effects on the CV system, and focus on exercise training and on established pharmacologic agents as well as those on the horizon. We conclude by summarizing the surgical therapeutic options available to treat obesity and the evidence supporting the CV benefits of surgery, and discuss the potential adverse effects of both pharmacologic and surgical options. © 2010 Springer Science+Business Media, LLC.

引用

页码：21 / 35

页数：14

共 60 条

[1]

Lavie C.J., Milani R.V., Ventura H.O., Obesity and cardiovascular disease: Risk factor, paradox, and impact of weight loss, J Am Coll Cardiol, 53, pp. 1925-1932, (2009)

[2]

Klein S., Burke L.E., Bray G.A., Blair S., Allison D.B., Pi-Sunyer X., Hong Y., Eckel R.H., Clinical implications of obesity with specific focus on cardiovascular disease: A statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism, Circulation, 110, 18, pp. 2952-2967, (2004)

[3]

Poirier P., Giles T.D., Bray G.A., Hong Y., Stern J.S., Pi-Sunyer F.X., Eckel R.H., Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism, Circulation, 113, 6, pp. 898-918, (2006)

[4]

Lavie C.J., Osman A.F., Milani R.V., Mehra M.R., Body composition and prognosis in chronic systolic heart failure: The obesity paradox, American Journal of Cardiology, 91, 7, pp. 891-894, (2003)

[5]

Calle E.E., Thun M.J., Petrelli J.M., Rodriguez C., Heath Jr. C.W., Body-mass index and mortality in a prospective cohort of U.S. adults, New England Journal of Medicine, 341, 15, pp. 1097-1105, (1999)

[6]

Manson J.E., Bassuk S.S., Obesity in the United States: A fresh look at its high toll, Journal of the American Medical Association, 289, 2, pp. 229-230, (2003)

[7]

Artham S.M., Lavie C.J., Milani R.V., Et al., The obesity paradox: Impact of obesity on the prevalence and prognosis of cardiovascular diseases, Postgrad Med, 120, pp. 34-41, (2008)

[8]

Lavie C.J., Milani R.V., Artham S.M., Et al., The obesity paradox, weight loss, and coronary disease, Am J Med, 122, pp. 1106-1114, (2009)

[9]

Lavie C.J., Messerli F.H., Cardiovascular adaptation to obesity and hypertension, Chest, 90, pp. 275-279, (1986)

[10]

Lavie C.J., Milani R.V., Patel D., Et al., Disparate effects of obesity and left ventricular geometry on mortality in 8088 elderly patients with preserved systolic function, Postgrad Med, 121, pp. 119-125, (2009)

← 1 2 3 4 5 6 →